Published in TB and Outbreaks Week, October 26th, 2004
The Procleix Ultrio Assay was developed to simultaneously detect HIV-1, hepatitis C virus (HCV) and hepatitis B virus (HBV) in donated blood, plasma, organs and tissue. The companies intend to seek approval to run the test on both the semi-automated Procleix System and on the fully automated, high-throughput Procleix TIGRIS System.
The Procleix Ultrio Assay adds a test for HBV to the previously approved Procleix HIV-1/HCV Assay....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.